Relish Pharmaceuticals Board to consider September quarter results
On 14 November 2016
Relish Pharmaceuticals announced that the meeting of the Board of Directors of the Company will be held on 14 November 2016 inter alia, to transact the following business:- To consider, adopt and approve Unaudited Financial Results for the quarter ended on 30 September 2016.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content